FDA Clears Quest's Respiratory Virus Molecular Test
December 01, 2010
FDA Clears Quest's Respiratory Virus Molecular Test
The Focus Diagnostics Simplexa Flu A/B & RSV test is intended to aid in the detection and discrimination of influenza A, influenza B, and respiratory syncytial virus infections.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- FDA Clears Focus Diagnostics' Flu Test on 3M Integrated Cycler
October 9, 2012 / GenomeWeb Daily News - FDA Clears Quest's C. difficile Molecular Test
April 11, 2012 / GenomeWeb Daily News - FDA Clears Cepheid Test for Influenza A/B, H1N1
April 26, 2011 / GenomeWeb Daily News - Focus Diagnostics Awaits CE Mark, FDA Clearance for Combined Flu/RSV Test on 3M Instrument
August 26, 2010 / PCR Insider - Quest Diagnostics Receives First FDA Clearance for H1N1 MDx Test
May 24, 2010 / GenomeWeb Daily News